Effect of high-dose simvastatin on cognition in secondary progressive multiple sclerosis (MS-STAT cognitive): a randomised, placebo-controlled, Phase 2 trial.

Effect of high-dose simvastatin on cognition in secondary progressive multiple sclerosis (MS-STAT cognitive): a randomised, placebo-controlled, Phase 2 trial.

Published version

Peer-reviewed

Repository URI

https://www.repository.cam.ac.uk/handle/1810/279547

Repository DOI

https://doi.org/10.17863/CAM.26919

Files

Published version (412.11 KB)

Type

Authors

Chan, Dennis

https://orcid.org/0000-0002-4265-3718

Journal Title

MULTIPLE SCLEROSIS JOURNAL

Journal ISSN

1352-4585
1477-0970

Volume Title

22

Rights and licensing

Attribution 4.0 International (CC BY 4.0)

Except where otherwised noted, this item's license is described as Attribution 4.0 International (CC BY 4.0)

Collections

University of Cambridge Research Outputs (Articles and Conferences)